NI
VRDN icon

Numeric Investors’s Viridian Therapeutics VRDN Stock Holding History

Numeric Investors’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$565K Buy
+3,614
New +$460K ﹤0.01% 866

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

Numeric Investors's VRDN Position: Q4 2017 in Review

Numeric Investors opened a new position in Viridian Therapeutics (VRDN) in Q4 2017: 3,614 shares worth $565K. The stake represents ﹤0.01% of the portfolio and ranks #866 among its holdings.

51 funds tracked by Wall St. Rank hold VRDN as of Q4 2017.

  • Numeric Investors held 3,614 shares of Viridian Therapeutics worth $565K as of Q4 2017.
  • Viridian Therapeutics was a new Numeric Investors position in Q4 2017.
  • Viridian Therapeutics made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #866 holding.
  • 51 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.